2009

1. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

   British Journal of Cancer, Vol. 100, Núm. 7, pp. 1111-1119